ArticleHaematologica2016

Acute myeloid leukemia patients' clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts.

Bernhard Reis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.